# FDA 483 - Baptist Health Deaconess Madisonville Inc - April 24, 2025

Source: https://www.keypedia.com/records/483/baptist-health-deaconess-madisonville-inc/25827dc5-500c-4f66-b2a6-a7b428484ebd

> FDA 483 for Baptist Health Deaconess Madisonville Inc on April 24, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Baptist Health Deaconess Madisonville Inc
- Inspection Date: 2025-04-24
- Product Type: biologics
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Baptist Health Deaconess Madisonville Inc, a blood bank, revealed two significant observations. The firm failed to thoroughly investigate unexplained ABO blood type discrepancies and did not conduct a root cause analysis. Additionally, the firm's standard operating procedures for donor phlebotomy were not adequately established or followed, specifically regarding the inversion of blood collection tubes.

## Related Officers

- [Cody D. Rickman](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)

Company: https://www.keypedia.com/companies/baptist-health-deaconess-madisonville-inc/a3da1335-ee83-4e02-bdbc-4d1b93555e82

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22